Résumé
Le concept de glomérulopathie paranéoplasique a été initialement évoqué par Galloway en 1922, avec l’association d’une maladie de Hodgkin et d’un syndrome néphrotique (1). Après cette première description, de nombreux cas d’association entre cancer et atteinte rénale sont rapportés. Cependant, l’existence d’un lien de causalité entre cancer et atteinte rénale reste discutée (2, 3). La définition même du terme «paranéoplasique» implique une relation temporelle forte entre le symptôme (ou son évolution) et la néoplasie (ou son évolution). S’il existe des cas publiés d’amélioration rapide des paramètres rénaux après prise en charge tumorale (4), et a contrario des cas d’aggravation rénale après récidive néoplasique (5), il existe également des évolutions dissociées (6). Dans ce cas, l’origine paranéoplasique doit être remise en question, même s’il n’existe pas à l’évidence d’autre étiologie à la glomérulopathie.
Preview
Unable to display preview. Download preview PDF.
Références
Galloway J (1922) Remarks on Hodgkin’s disease. Br Med (2):1201–4
Ronco PM (1999) Paraneoplastic glomerulopathies: new insights into an old entity. Kidney Int 56: 355–77
Lefaucheur C, Stengel B, Nochy D, et al. (2006) Membranous nephropathy and cancer: Epidemiologic evidence and determinants of high-risk cancer association. Kidney Int 70: 1510–7
Yamauchi H, Linsey MS, Biava CG, Hopper J, Jr. (1985) Cure of membranous nephropathy after resection of carcinoma. Arch Intern Med 145: 2061–3
Burstein DM, Korbet SM, Schwartz MM (1993) Membranous glomerulonephritis and malignancy. Am J Kidney Dis 22: 5–10
Couser WG, Wagonfeld JB, Spargo BH, Lewis EJ (1974) Glomerular deposition of tumor antigen in membranous nephropathy associated with colonic carcinoma. Am J Med 57: 962–70
Davison A, Hartley B (2005) Malignancy-associated glomerular disease. In: Davison A, Cameron J, Grünfeld J, et al., editors. Oxford Textbook of Clinical Nephrology. Oxford: Oxford University Press, p. 625–38
Nomura S, Takeda M, Manabe T, et al. (1995) Case report: intraglomerular metastasis with neoplastic cell interposition. Am J Med Sci 309: 179–82
Donckerwolcke R, Cameron J (2005) The nephrotic syndrome. In: Davison A, Cameron J, Grünfeld J, et al., (eds). Oxford Textbook of Clinical Nephrology. Oxford: Oxford University Press, p. 415–38
Lam KY, Law SY, Chan KW, Yuen MC (1998) Glomerulonephritis associated with basaloid squamous cell carcinoma of the oesophagus. A possible unusual paraneoplastic syndrome. Scand J Urol Nephrol 32: 61–3
Magyarlaki T, Kiss B, Buzogany I, et al. (1999) Renal cell carcinoma and paraneoplastic IgA nephropathy. Nephron 82: 127–30
Loi S, Perry GJ, Standish H, Dowling J (2004) Glomerulosclerosis: a paraneoplastic phenomenon? Nephrology (Carlton) 9: 387–91
Paydas S, Soydas B, Paydas S, et al. (2005) Different glomerulopathies accompanying non-small-cell lung cancer. Mt Sinai J Med 72: 279–81
Maes B, Vanwalleghem J, Kuypers D, et al. (1999) IgA antiglomerular basement membrane disease associated with bronchial carcinoma and monoclonal gammopathy. Am J Kidney Dis 33: E3
Altiparmak MR, Pamuk GE, Pamuk ON (2003) Adrenal carcinoma causing secondary amyloidosis: report of the first case in the literature. Neth J Med 61: 142–5
Audard V, Larousserie F, Grimbert P, et al. (2006) Minimal change nephrotic syndrome and classical Hodgkin’s lymphoma: report of 21 cases and review of the literature. Kidney Int 69: 2251–60
Lee JC, Yamauchi H, Hopper J, Jr. (1966) The association of cancer and the nephrotic syndrome. Ann Intern Med 64: 41–51
Zech P, Colon S, Pointet P, et al. (1982) The nephrotic syndrome in adults aged over 60: etiology, evolution and treatment of 76 cases. Clin Nephrol 17: 232–6
Birkeland SA, Storm HH (2003) Glomerulonephritis and malignancy: a population-based analysis. Kidney Int 63: 716–21
Puolijoki H, Mustonen J, Pettersson E, et al. (1989) Proteinuria and haematuria are frequently present in patients with lung cancer. Nephrol Dial Transplant 4: 947–50
Sawyer N, Wadsworth J, Wijnen M, Gabriel R (1988) Prevalence, concentration, and prognostic importance of proteinuria in patients with malignancies. Br Med J (Clin Res Ed) 296: 1295–8
Davison AM (2001) Renal diseases associated with malignancies. Nephrol Dial Transplant 16 Suppl 6: 13–4
Karras A, de Montpreville V, Fakhouri F, et al. (2005) Renal and thymic pathology in thymoma-associated nephropathy: report of 21 cases and review of the literature. Nephrol Dial Transplant 20: 1075–82
Tourneur F, Bouvier R, Langue J, et al. (2000) Membranous nephropathy and orbital malignant tumor. Pediatr Nephrol 14: 53–5
Niaudet P, Gubler MC (2006) WT1 and glomerular diseases. Pediatr Nephrol 21: 1653–60
Tsai HM (2003) Advances in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura. J Am Soc Nephrol 14: 1072–81
Werner TL, Agarwal N, Carney HM, Rodgers GM (2007) Management of cancer-associated thrombotic microangiopathy: what is the right approach? Am J Hematol 82: 295–8
Pena de la Vega L, Fervenza FC, Lager D, et al. (2005) Acute granulomatous interstitial nephritis secondary to bisphosphonate alendronate sodium. Ren Fail 27: 485–9
Braden GL, O’Shea MH, Mulhern JG (2005) Tubulointerstitial diseases. Am J Kidney Dis 46: 560–72
Bacchetta J, Juillard L, Cochat P, Droz JP (2009) Paraneoplastic glomerular diseases and malignancies. Crit Rev Oncol Hematol 70(1): 39–58
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag France, Paris
About this chapter
Cite this chapter
Bacchetta, J., Juillard, L., Cochat, P., Droz, JP. (2010). Rénaux. In: Tumeurs malignes rares. Springer, Paris. https://doi.org/10.1007/978-2-287-72070-3_45
Download citation
DOI: https://doi.org/10.1007/978-2-287-72070-3_45
Publisher Name: Springer, Paris
Print ISBN: 978-2-287-72069-7
Online ISBN: 978-2-287-72070-3